Pharminent

GSK commences phase III study for triple combination asthma therapy

GlaxoSmithKline (GSK) and Innoviva have started started a triple combination therapy phase III study for the treatment of asthma. http://processandproduction.pharmaceutical-business-review.com/news/gsk-commences-phase-iii-study-for-triple-combination-asthma-therapy-201216-5701328

Filed under: Respiratory